English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genentech Inc.
Press release submission
| Sep 16, 2018
GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Trending
+
Community
Patient Daily
| Nov 1, 2024
Community raises over $135,000 from GoFundMe, National Breathe Free donation for Tempe Fire Captain
+
Pharmaceuticals
Patient Daily
| Oct 29, 2024
Fight For Air Climb returns to Orlando in March
+
Pharmaceuticals
Patient Daily
| Oct 31, 2024
American Lung Association promotes actions during Lung Cancer Awareness Month
+
Pharmaceuticals
Patient Daily
| Oct 30, 2024
Healthcare open enrollment begins November 1 with new eligibility expansions
